Find the latest pharmaceutical market place for APIs enquiry about Ebastine on PharmaCompass.com.

Ebastine (MOQ) API needed in Egypt [ENA20740]

A company that focuses on distibution of various pharmaceutical and cosmetic products is looking for suppliers of Ebastine (MOQ) API for commercial purposes. The suppliers must support this enquiry with DMF, GMP & CoA.

Reply

04 Oct 2024

Ebastine (200 kg) API needed in China [ENA20167]

A company that focuses on development, manufacturing and distribution of various APIs, intermediates and finished formulations is looking for suppliers of Ebastine (200 kg) API for commercial purposes. The suppliers must support this enquiry with CEP & CoA.

Reply

02 Aug 2024

USP Grade Ebastine (20 kg) API needed in Pakistan [ENA18743]

A company that focuses on distribution of various pharmaceutical products is looking for suppliers of USP Grade Ebastine (20 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.

Reply

08 Dec 2023

Bangladesh Flag

Ebastine (10 kg) API needed in Bangladesh [ENA16398]

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Ebastine (10 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.

Reply

16 Feb 2023

Ebastine (MOQ) API needed in China [ENA15175]

A company based in India that focuses on research & development of pre-formulation assessments, stable, scalable, robust and efficient technology transfer processes is looking for suppliers of Ebastine (MOQ) API for development purpose. The suppliers must support this enquiry with CEP or JDMF.

Reply

30 Sep 2022

india-flag Flag

Various APIs needed in India [ENA13702]

A company that deals in distributor of APIs and intermediates for human & veterinary use is looking for suppliers of Various APIs for commercial purpose. The suppliers must support this enquiry with CoA.
1. Rifaximin API
2. Ebastine API
3. Famotidine API
4. Montelukast Sodium API

Reply

20 May 2022

india-flag Flag

Various APIs needed in India [ENA10173]

A company that deals in pharmaceutical products is looking for suppliers of Various APIs.
1. Aceclofenac (100 kg) API
2. IP Grade Artemether (5 kg) API
3. Azithromycin (100 kg) API
4. Benzoyl Peroxide (10 kg) API
5. Betahistine (5 kg) API
6. Calcium Dobesilate (25 kg) API
7. Clonazepam (500 g) API
8. Dicalcium Phosphate (250 kg) API
9. Diclofenac (50 kg) API
10. Disodium Hydrogen Citrate (100 kg) API
11. Divalproex Sodium (50 kg) API
12. Doxofylline (25 kg) API
13. Drotaverine (50 kg) API
14. Ebastine (5 kg) API
15. Escitalopram (2 kg) API
16. Febuxostat (5 kg) API
17. Fluconazole (10 kg) API
18. Fusidic Acid (5 kg) API
19. Gabapentin (25 kg) API
20. Glucosamine (25 kg) API
21. Ketoconazole (25 kg) API
22. L-Glutathione (20 kg) API
23. Linezolid (20 kg) API
24. Norfloxacin (15 kg) API
25. Thiocolchicoside (1 kg) API
26. Tinidazole (20 kg) API
27. Tretinoin (500 g) API
28. Ursodeoxycholic Acid (15 kg) API
29. Valacyclovir (25 kg) API
30. Telmisartan (20 kg) API
31. Mefenamic Acid (100 kg) API
32. Aspartame (25 kg) API
33. Calcium Citrate (500 kg) API
34. Paracetamol (300 kg) API
35. Itraconazole (50 kg) API

Reply

09 Apr 2021

Doxofylline and various APIs needed in Pakistan [ENA04925] [Part 2/2]

[Part 2/2] A leading pharmaceutical manufacturing company in Pakistan is looking for European/American/ Chinese/Japanese/ Taiwan suppliers/manufacturers of mentioned APIs.
1. Doxofylline
2. Ebastin
3. Hydroquinone
4. Alfacalcidol
5. Alprazolam
6. Lidocaine HCl
7. Linezolid
8. Midazolam HCl
9. Tacrolimus Monohydrate
10. Zolpidem Hemitartrate.

Reply

19 Aug 2019

Roflumilast, Acyclovir and other APIs needed in Pakistan [ENA03829]

A leading pharmaceutical company in Pakistan is looking for Chinese/European suppliers/manufacturers of below APIs with GMP certificate and DMF support for domestic consumption:
1. Acyclovir
2. Adapalene
3. Alprazolam
4. Bupivacaine Hydrochloride
5. Buprenorphine hydrochloride
6. Cefotaxime
7. Ceftazidime
8. Ciprofloxacin HCl
9. Dexamethasone Sodium Phosphate
10. Diclofenac Potassium
11. Diclofenac Sodium
12. Diphenhydramine
13. Doxofylline
14. Ebastine
15. Eflornithine
16. Fentanyl Citrate
17. Fluocinolone Acetonide
18. Glimepiride
19. Hydroquinone
20. Hydroxypropyl Cellulose
21. Iron (III) Hydroxide Polymaltose Complex
22. Lidocaine Hydrochloride
23. Linezolid
24. Lisinopril
25. Losartan Potassium
26. Midazolam
27. Moxifloxacin HCl (Tab and Inj Grade)
28. Nalbuphine HCl
29. Neostigmine Methyl sulphate
30. Omeprazole Pellets 8.5%
31. Riboflavin Sodium Phosphate
32. Rifaximin
33. Roflumilast
34. Tacrolimus
35. Terbinafine
36. Tramadol

Reply

03 Apr 2019

Ebastine pellets needed in Egypt [ENA02963]

Namaa for Trading & Agencies in Egypt is looking for suppliers of Ebastine pellets with GMP and COA. Interested suppliers can contact Dr Amira Saeed via Mob: +202 26206 957 or E-mail: namaa@namaatrading.com.

Reply

17 Dec 2018

Ebastine and Neostigmine APIs needed in Pakistan [ENA02476]

A leading pharmaceutical company in Pakistan is looking for Chinese or European suppliers of Ebastine and Neostigmine APIs for domestic consumption.

Reply

29 Oct 2018

CEP grade Ebastine API (10kg) needed in Romania [ENA01903]

A solid pharmaceutical company with a harmonious development in the areas of research, production and distribution is looking for suppliers of CEP grade Ebastine API (10kg). Interested suppliers must support this enquiry with Certificate of Analysis (COA).

Reply

14 Sep 2018

Enquiry// Loxoprofen, Montelukast Sodium, Dextromethorphan Hydrobromide and many other APIs needed in Vietnam [EN...

Sun VN Import Export Joint Stock Company, an API and Chemical Distributor in Vietnam is looking to buy the following APIs for supply
Loxoprofen Sodium Dihydrate 200 kg
Montelukast Sodium 10 kg
Dextromethorphan Hydrobromide 100kg
Cefdinir 100 kg
Clopidogrel BiSulfate 100 kg
Rosuvastatin Calcium 500 g
Perindopril Erbumin 2 kg
Buprenorphine Hydrochloride 100 g
Bambuterol HCl BP 2013 10 kg
Quinapril Hydrocloride 5 kg
Enalapril Maleate 10 kg
Ebastine BP 2013 5 kg and
Entecavir 500 g

Reply

17 Jan 2017